Bayrak EBT Valuation Multiples

Bayrak EBT is valued at $17M as of September 2026, a 4.6x revenue multiple. In the last fiscal year, Bayrak EBT revenue was $5M and Bayrak EBT EBITDA was ($2M).

Bayrak EBT Overview

About Bayrak EBT

Bayrak EBT Taban Sanayi ve Ticaret AS is engaged in the manufacturing of PVC shoe soles.


Founded

1993

HQ

Turkey

Employees

N/A

Financials (Last FY)

Revenue: $5M
EBITDA: ($2M)

EV

$22M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Bayrak EBT Financials

Bayrak EBT reported last fiscal year revenue of $5M and negative EBITDA of ($2M).

In the same fiscal year, Bayrak EBT generated $37K in gross profit, ($2M) in EBITDA losses, and had net loss of ($4M).


Bayrak EBT P&L

In the most recent fiscal year, Bayrak EBT reported revenue of $5M and EBITDA of ($2M).

Bayrak EBT is unprofitable as of last fiscal year, with gross margin of 1%, EBITDA margin of (40%), and net margin of (85%).

See analyst estimates for Bayrak EBT
Last FY2025202620272028
Revenue$5M$5M
Gross Profit$37K$37K
Gross Margin1%1%
EBITDA($2M)($2M)
EBITDA Margin(40%)(40%)
EBIT Margin(50%)(50%)
Net Profit($4M)($4M)
Net Margin(85%)(85%)
Net Debt$4M-

Financial data powered by Morningstar, Inc.

Bayrak EBT Stock Performance

Bayrak EBT has current market cap of $17M, and enterprise value of $22M.


Bayrak EBT's stock price is $0.07.

Bayrak EBT has an EPS (earnings per share) of $-0.02.

See more trading valuation data for Bayrak EBT
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$22M$17M-7.0%---$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Bayrak EBT Valuation Multiples

Bayrak EBT trades at 4.6x EV/Revenue multiple, and (11.3x) EV/EBITDA.

See NTM and 2027E valuation multiples for Bayrak EBT

Bayrak EBT Financial Valuation Multiples

As of September 22, 2026, Bayrak EBT has market cap of $17M and EV of $22M.

Bayrak EBT has a P/E ratio of (4.2x).

Last FY2025202620272028
EV/Revenue4.6x4.6x
EV/EBITDA(11.3x)(11.3x)
EV/EBIT(9.0x)(9.0x)
EV/Gross Profitn/mn/m
P/E(4.2x)(4.2x)
EV/FCF(5.2x)(5.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Bayrak EBT Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Bayrak EBT Margins & Growth Rates

In the most recent fiscal year, Bayrak EBT reported gross margin of 1%, EBITDA margin of (40%), and net margin of (85%).

See estimated margins and future growth rates for Bayrak EBT

Bayrak EBT Margins

Last FY2025202720282029
Gross Margin1%1%
EBITDA Margin(40%)(40%)
EBIT Margin(50%)(50%)
Net Margin(85%)(85%)
FCF Margin(88%)(88%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Bayrak EBT Operational KPIs

Access forward-looking KPIs for Bayrak EBT
Last FY2025202620272028
S&M Expenses to Revenue2%2%
G&A Expenses to Revenue2%2%
Opex to Revenue51%51%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Bayrak EBT Competitors

Bayrak EBT competitors include Step One Clothing, iWin, Carboclor, Aeffe, Le Slip Francais, Polwax, Sodaş Sodyum, elumeo, Elbit Realestate and Melamin.

Most Bayrak EBT public comparables operate across Clothing & Accessories and Chemicals.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Step One Clothing$45M($5M)----
iWin$84M$8M0.3x-3.5x-
Carboclor$11M$2M1.2x-7.3x-
Aeffe$413M$91M0.3x-1.3x-
Le Slip Francais------
Polwax$34M($4M)0.4x-(3.9x)-
Sodaş Sodyum$6M($379K)2.4x-(35.2x)-
elumeo$45M($2M)0.4x0.4x(7.7x)43.1x

This data is available for Pro users. Sign up to see all Bayrak EBT competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Bayrak EBT

When was Bayrak EBT founded?Bayrak EBT was founded in 1993.
Where is Bayrak EBT headquartered?Bayrak EBT is headquartered in Turkey.
Is Bayrak EBT publicly listed?Yes, Bayrak EBT is a public company listed on Borsa Istanbul.
What is the stock symbol of Bayrak EBT?Bayrak EBT trades under BAYRK ticker.
When did Bayrak EBT go public?Bayrak EBT went public in 2020.
Who are competitors of Bayrak EBT?Bayrak EBT main competitors include Step One Clothing, iWin, Carboclor, Aeffe, Le Slip Francais, Polwax, Sodaş Sodyum, elumeo, Elbit Realestate, Melamin.
What is the current market cap of Bayrak EBT?Bayrak EBT's current market cap is $17M.
What is the current revenue of Bayrak EBT?Bayrak EBT's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Bayrak EBT?Current revenue multiple of Bayrak EBT is 4.6x.
Is Bayrak EBT profitable?No, Bayrak EBT is not profitable.
How many companies Bayrak EBT has acquired to date?Bayrak EBT hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Bayrak EBT has invested to date?Bayrak EBT hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Bayrak EBT

Lists including Bayrak EBT

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial